Enrollment for this clinical trial has closed.

We are very excited to share that Neuren Pharmaceuticals has officially opened the enrollment for the open-label study of oral NNZ-2591 in Pitt Hopkins syndrome.

More details can be found at the following two websites:

• https://pthsstudy.com

• https://clinicaltrials.gov/ct2/show/NCT05025332?cond=pitt+hopkins&draw=2&rank=1

Clinic sites for the trial are below. Please reach out to the specific location with questions and for enrollment.

University of Alabama at Birmingham – Recruiting
Birmingham, Alabama, United States, 35294
Contact: Cassandra Newsom, 205-934-2352, Cassandranewsom@uabmc.edu

University of California at San Francisco – Recruiting
San Francisco, California, United States, 94143
Contact: Alison Walmsley, 408-334-5630, alison.walmsley@ucsf.edu

Children’s Hospital Colorado – Recruiting
Aurora, Colorado, United States, 80045
Contact: Eliana Obando, 720-777-5378, eliana.obando@childrenscolorado.org

Rush University Medical Center – Recruiting 
Chicago, Illinois, United States, 60612
Contact: Allison Baumann, 312-942-2005, Allison_L_Baumann@rush.edu

UT Southwestern – Recruiting
Dallas, Texas, United States, 75390
Contact: Jessica Clark, 972-655-4847, Jessica.clark@utsouthwestern.edu

Information on travel support can be found here.